| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.154 | 9.481 | 15.392 | 25.490 | 29.712 | 33.793 |
| Total Income - EUR | - | - | - | - | 3.249 | 9.482 | 15.392 | 25.490 | 29.721 | 34.399 |
| Total Expenses - EUR | - | - | - | - | 3.933 | 6.166 | 7.616 | 11.795 | 13.746 | 20.915 |
| Gross Profit/Loss - EUR | - | - | - | - | -684 | 3.316 | 7.776 | 13.695 | 15.975 | 13.484 |
| Net Profit/Loss - EUR | - | - | - | - | -748 | 3.124 | 7.459 | 13.177 | 15.195 | 11.444 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Tiana Biomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 11.097 | 8.176 | 6.237 | 3.096 | 796 | 20.088 |
| Current Assets | - | - | - | - | 1.740 | 8.009 | 5.666 | 20.223 | 37.533 | 26.539 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 390 | 1.763 | 1.986 | 12.867 | 25.945 | 10.936 |
| Cash | - | - | - | - | 1.350 | 6.245 | 3.681 | 2.793 | 7.040 | 15.602 |
| Shareholders Funds | - | - | - | - | -706 | 2.432 | 9.837 | 23.045 | 38.170 | 28.668 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 13.543 | 13.753 | 2.067 | 274 | 159 | 17.959 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tiana Biomed S.r.l.